Lack of efficacy and cost-effectiveness of drug-eluting stents

The findings of the meta-analysis about the comparative efficacy of drug-eluting stents (DESs) compared with bare-metal stents (BMSs) by Nordmann et al .1 both re-affirm and enhance those observed in previous research. Katritsis et al .2 have also demonstrated the lack of any efficacy superiority of DES over BMS, during the relatively short-term follow-up of between six and 12 months from intervention. Unsurprisingly for a health intervention with questionable clinical efficacy, the cost-effectiveness ratios of the current practice of nearly routine use …